184163-49-3

Basic information

• Product Name: 2-chloro-5-hydrazinylbenzoic acid hydrochloride (1:1)
• Synonyms: 2-chloro-5-hydrazinylbenzoic Acid Hydrochloride
• CAS NO: 184163-49-3
• Molecular Formula: C₇H₈Cl₂N₂O₂
• Molecular Weight: 223.0566
• Mol File: 184163-49-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 405.4°C at 760 mmHg
• Flash Point: 199°C
• Vapor Pressure: 2.68E-07mmHg at 25°C
• CAS DataBase Reference: 2-chloro-5-hydrazinylbenzoic acid hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-5-hydrazinylbenzoic acid hydrochloride (1:1)(184163-49-3)
• EPA Substance Registry System: 2-chloro-5-hydrazinylbenzoic acid hydrochloride (1:1)(184163-49-3)

Safety Data

• Hazardous Substances Data: 184163-49-3(Hazardous Substances Data)

Upstream product

• 89-54-3 2-chloro-5-aminobenzoic acid 
• 24569-37-7 C₇H₄ClN₂O₂⁽¹⁺⁾*Cl^(1-) 

Downstream Products

• 676470-14-7 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-7-carboxylic acid 

Relevant articles and documents

Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma

Multiple myeloma (MM) cells demonstrate high basal endoplasmic reticulum (ER) stress and are typically exquisitely sensitive to agents such as proteasome inhibitors that activate the unfolded protein response. The flavin adenosine dinucleotide (FAD) conta

Dihydrodipyrazolopyridinylbenzamide and -sulfonamide inhibitors of B7-1

The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection or autoimmune disease.

Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharmaceutical compositions containing them

The invention relates to new substituted 1-phenyl-3-pyrazolecarboxamides having a great affinity for human neurotensin receptors, to a process for preparing them and to pharmaceutical compositions containing them as active principles. More particularly, this invention relates to the discovery that the affinity for neurotensin receptors, especially human neurotensin receptors, is increased by substituting the phenyl group of 1-phenyl-3-pyrazolecarboxamide compounds with particular groups.